spacer
spacer

PDBsum entry 2gv9

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Transferase PDB id
2gv9

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
981 a.a. *
1035 a.a. *
Ligands
SO4 ×2
GAI
Metals
_HG
Waters ×87
* Residue conservation analysis
PDB id:
2gv9
Name: Transferase
Title: Crystal structure of the herpes simplex virus type 1 DNA polymerase
Structure: DNA polymerase. Chain: a, b. Engineered: yes
Source: Human herpesvirus 1. Organism_taxid: 10306. Strain: kos. Gene: ul30. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108.
Resolution:
2.68Å     R-factor:   0.225     R-free:   0.281
Authors: S.Liu
Key ref:
S.Liu et al. (2006). Crystal structure of the herpes simplex virus 1 DNA polymerase. J Biol Chem, 281, 18193-18200. PubMed id: 16638752 DOI: 10.1074/jbc.M602414200
Date:
02-May-06     Release date:   16-May-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P04292  (DPOL_HHV1K) -  DNA polymerase catalytic subunit from Human herpesvirus 1 (strain KOS)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1235 a.a.
981 a.a.
Protein chain
Pfam   ArchSchema ?
P04292  (DPOL_HHV1K) -  DNA polymerase catalytic subunit from Human herpesvirus 1 (strain KOS)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1235 a.a.
1035 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 2: Chains A, B: E.C.2.7.7.7  - DNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 3: Chains A, B: E.C.3.1.26.4  - ribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Endonucleolytic cleavage to 5'-phosphomonoester.
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1074/jbc.M602414200 J Biol Chem 281:18193-18200 (2006)
PubMed id: 16638752  
 
 
Crystal structure of the herpes simplex virus 1 DNA polymerase.
S.Liu, J.D.Knafels, J.S.Chang, G.A.Waszak, E.T.Baldwin, M.R.Deibel, D.R.Thomsen, F.L.Homa, P.A.Wells, M.C.Tory, R.A.Poorman, H.Gao, X.Qiu, A.P.Seddon.
 
  ABSTRACT  
 
Herpesviruses are the second leading cause of human viral diseases. Herpes Simplex Virus types 1 and 2 and Varicella-zoster virus produce neurotropic infections such as cutaneous and genital herpes, chickenpox, and shingles. Infections of a lymphotropic nature are caused by cytomegalovirus, HSV-6, HSV-7, and Epstein-Barr virus producing lymphoma, carcinoma, and congenital abnormalities. Yet another series of serious health problems are posed by infections in immunocompromised individuals. Common therapies for herpes viral infections employ nucleoside analogs, such as Acyclovir, and target the viral DNA polymerase, essential for viral DNA replication. Although clinically useful, this class of drugs exhibits a narrow antiviral spectrum, and resistance to these agents is an emerging problem for disease management. A better understanding of herpes virus replication will help the development of new safe and effective broad spectrum anti-herpetic drugs that fill an unmet need. Here, we present the first crystal structure of a herpesvirus polymerase, the Herpes Simplex Virus type 1 DNA polymerase, at 2.7 A resolution. The structural similarity of this polymerase to other alpha polymerases has allowed us to construct high confidence models of a replication complex of the polymerase and of Acyclovir as a DNA chain terminator. We propose a novel inhibition mechanism in which a representative of a series of non-nucleosidic viral polymerase inhibitors, the 4-oxo-dihydroquinolines, binds at the polymerase active site interacting non-covalently with both the polymerase and the DNA duplex.
 
  Selected figure(s)  
 
Figure 2.
FIGURE 2. Unique functional domains of herpes simplex 1 DNA polymerase. A, a ribbon diagram of the pre-NH[2]-terminal domain in cyan, with electrostatic surface representation of the putative single-stranded DNA binding groove. For clarity, only surfaces from NH[2]-terminal and exonuclease domains are shown. The DNA duplex is modeled. B, ribbon diagram of the NH[2]-terminal domain embedded in the electrostatic surface representation to show the putative RNA binding cleft. The motif is on the left.
Figure 3.
FIGURE 3. HSV POL replicating and inhibiting model. A, replicating model. The carbon atoms of HSV POL shown in stick are light gray, whereas those of primer DNA strand and dTTP are dark gray and those of the template are purple. Black dashed lines are shown for hydrogen bonds and ion interactions involving the incoming nucleotide and catalytic ions. B, model of Acyclovir·HSV POL dead-end complex. Hydrogen bonds involving Acyclovir are shown in black dashes. Key residues interacting with the Acyclovir-incorporated DNA, including the conserved KKKY motif (938-941), are shown. C, chemical structure of PNU-183792, a 4-oxo-DHQ type of herpes polymerase inhibitor. D, a novel inhibition mechanism of a family of broad spectrum inhibitor 4-oxo-DHQ. Residues interacting with inhibitor are highlighted.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2006, 281, 18193-18200) copyright 2006.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20673774 R.E.Hubbard (2011).
Structure-based drug discovery and protein targets in the CNS.
  Neuropharmacology, 60, 7.  
20163964 E.Johansson, and S.A.Macneill (2010).
The eukaryotic replicative DNA polymerases take shape.
  Trends Biochem Sci, 35, 339-347.  
20200193 G.Ma, C.Lu, and N.Osterrieder (2010).
Residue 752 in DNA polymerase of equine herpesvirus type 1 is non-essential for virus growth in vitro.
  J Gen Virol, 91, 1817-1822.  
21039794 S.Pronost, R.F.Cook, G.Fortier, P.J.Timoney, and U.B.Balasuriya (2010).
Relationship between equine herpesvirus-1 myeloencephalopathy and viral genotype.
  Equine Vet J, 42, 672-674.  
19622750 E.P.Tchesnokov, A.Obikhod, R.F.Schinazi, and M.Götte (2009).
Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.
  J Biol Chem, 284, 26439-26446.  
19759157 J.L.Baltz, D.J.Filman, M.Ciustea, J.E.Silverman, C.L.Lautenschlager, D.M.Coen, R.P.Ricciardi, and J.M.Hogle (2009).
The crystal structure of PF-8, the DNA polymerase accessory subunit from Kaposi's sarcoma-associated herpesvirus.
  J Virol, 83, 12215-12228.
PDB codes: 3hsl 3i2m
19718023 M.K.Swan, R.E.Johnson, L.Prakash, S.Prakash, and A.K.Aggarwal (2009).
Structural basis of high-fidelity DNA synthesis by yeast DNA polymerase delta.
  Nat Struct Mol Biol, 16, 979-986.
PDB code: 3iay
19166354 N.A.Cavanaugh, M.Urban, J.Beckman, T.E.Spratt, and R.D.Kuchta (2009).
Identifying the features of purine dNTPs that allow accurate and efficient DNA replication by herpes simplex virus I DNA polymerase.
  Biochemistry, 48, 3554-3564.  
19420083 W.Tian, Y.T.Hwang, Q.Lu, and C.B.Hwang (2009).
Finger domain mutation affects enzyme activity, DNA replication efficiency, and fidelity of an exonuclease-deficient DNA polymerase of herpes simplex virus type 1.
  J Virol, 83, 7194-7201.  
18552872 C.Y.Hsiang, and T.Y.Ho (2008).
Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures.
  Br J Pharmacol, 155, 227-235.  
18842735 D.B.Gammon, R.Snoeck, P.Fiten, M.Krecmerová, A.Holý, E.De Clercq, G.Opdenakker, D.H.Evans, and G.Andrei (2008).
Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs.
  J Virol, 82, 12520-12534.  
18695225 F.Bogani, and P.E.Boehmer (2008).
The replicative DNA polymerase of herpes simplex virus 1 exhibits apurinic/apyrimidinic and 5'-deoxyribose phosphate lyase activities.
  Proc Natl Acad Sci U S A, 105, 11709-11714.  
17959669 K.F.Bryant, and D.M.Coen (2008).
Inhibition of translation by a short element in the 5' leader of the herpes simplex virus 1 DNA polymerase transcript.
  J Virol, 82, 77-85.  
18214976 N.B.de la Cruz, F.C.Peterson, and B.F.Volkman (2008).
Solution structure of At3g28950 from Arabidopsis thaliana.
  Proteins, 71, 546-551.
PDB code: 2jqv
17942550 S.Chou, and G.I.Marousek (2008).
Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.
  J Virol, 82, 246-253.  
18502683 S.Chou, G.Marousek, S.Li, and A.Weinberg (2008).
Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locus.
  J Clin Virol, 43, 107-109.  
18596099 W.Tian, Y.T.Hwang, and C.B.Hwang (2008).
The enhanced DNA replication fidelity of a mutant herpes simplex virus type 1 DNA polymerase is mediated by an improved nucleotide selectivity and reduced mismatch extension ability.
  J Virol, 82, 8937-8941.  
17043128 G.M.Scott, A.Weinberg, W.D.Rawlinson, and S.Chou (2007).
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
  Antimicrob Agents Chemother, 51, 89-94.  
17166725 H.Choo, J.R.Beadle, Y.Chong, J.Trahan, and K.Y.Hostetler (2007).
Synthesis of the 5-phosphono-pent-2-en-1-yl nucleosides: a new class of antiviral acyclic nucleoside phosphonates.
  Bioorg Med Chem, 15, 1771-1779.  
17997600 L.B.Goodman, A.Loregian, G.A.Perkins, J.Nugent, E.L.Buckles, B.Mercorelli, J.H.Kydd, G.Palù, K.C.Smith, N.Osterrieder, and N.Davis-Poynter (2007).
A point mutation in a herpesvirus polymerase determines neuropathogenicity.
  PLoS Pathog, 3, e160.  
17709468 S.Chou, G.I.Marousek, L.C.Van Wechel, S.Li, and A.Weinberg (2007).
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens.
  Antimicrob Agents Chemother, 51, 4160-4162.  
17085042 J.R.Mesters, J.Tan, and R.Hilgenfeld (2006).
Viral enzymes.
  Curr Opin Struct Biol, 16, 776-786.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer